Underuse of Effective Cardiac Medications Among Women, Middle-Aged Adults, and Racial/Ethnic Minorities With Coronary Artery Disease (from the National Health and Nutrition Examination Survey 2005 to 2014)
- 1 October 2017
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 120 (8) , 1223-1229
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Cardiovascular Medication Use Following Percutaneous Coronary Intervention: The Australian ExperienceCardiovascular Therapeutics, 2014
- Polypills for cardiovascular prevention: a step forward?Nature Reviews Cardiology, 2013
- AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 UpdateJACC, 2011
- Variable selection: current practice in epidemiological studiesEuropean Journal of Epidemiology, 2009
- Trends in the Use of Evidence-Based Treatments for Coronary Artery Disease Among Women and the ElderlyCirculation: Cardiovascular Quality and Outcomes, 2009
- Trends in adherence to secondary prevention medications in elderly post‐myocardial infarction patientsPharmacoepidemiology and Drug Safety, 2008
- Ten-Year Trends of Cardiovascular Drug Use After Myocardial Infarction Among Community-Dwelling Persons ≥65 Years of AgeThe American Journal of Cardiology, 2007
- Relationship Between Adherence to Evidence-Based Pharmacotherapy and Long-term Mortality After Acute Myocardial InfarctionJAMA, 2007
- Sex and Racial Differences in the Management of Acute Myocardial Infarction, 1994 through 2002New England Journal of Medicine, 2005
- AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 updateJACC, 2001